New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 14, 2014
06:08 EDTACHNAchillion announces clinical results for ACH-3102
Achillion announced updated Phase 2 clinical trial results evaluating a 150 mg loading dose followed by 50 mg once daily of ACH-3102 in combination with either once daily 200 mg or 400 mg of sovaprevir and twice daily ribavirin showed that 100% of patients achieved SVR12 including subjects who had Y93 mutations at baseline. A second oral presentation on ACH-3102 was made at APASL 2014 that discussed clinical virology and the lack of virologic breakthrough that was observed in the novel Phase 2 clinical trial evaluating ACH-3102 with ribavirin for patients with treatment-na´ve genotype 1b HCV. Despite the presence of up to six linked mutations identified at baseline in the NS5A protein, ACH-3102, without the co-administration of interferon or a second direct-acting antiviral, was able to suppress viral replication with no virologic breakthrough observed during 12 weeks of treatment.
News For ACHN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 28, 2014
06:07 EDTACHNStocks with implied volatility above IV index mean; DG ACHN
Subscribe for More Information
November 26, 2014
13:35 EDTACHNAchillion volatility elevated
Subscribe for More Information
13:25 EDTACHNAchillion to benefit from Bristol-Myers CRL, says FBR Capital
FBR Capital expects Achillion (ACHN) to benefit from the complete response letter that the FDA sent to Bristol-Myers (BMY) on its daclatasvir HCV drug. The firm thunks the letter increases the value of GT-3 HCV patients for Achillion. FBR says that GT-3 patients constitute 5% of HCV patients in the U.S. and significantly higher in Europe. It keeps an Outperform rating on Achillion.
13:11 EDTACHNAchillion mentioned positively at FBR Capital
06:07 EDTACHNStocks with implied volatility above IV index mean; DG ACHN
Subscribe for More Information
November 19, 2014
05:44 EDTACHNStocks with implied volatility movement; MCD KO
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use